A Balanced Approach for Cannabidiol Use in Chronic Pain
Abstract Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa L., has gained traction as a potential treatment for intractable…
Abstract Cannabidiol (CBD), the major non-psychoactive constituent of Cannabis sativa L., has gained traction as a potential treatment for intractable…
Abstract GPR18 is an orphan G protein-coupled receptor (GPCR) expressed in cells of the immune system. It is activated by…
Abstract Emerging evidence points to the role of the endocannabinoid system in long-term stress-induced neural remodeling with studies on stress-induced…
Abstract Opioid analgesics represent a critical treatment for chronic pain in the analgesic ladder of the World Health Organization. However,…
Abstract The cannabinoid receptor CB1 regulates differentiation of spermatids. We recently characterized spermatozoa from caput epididymis of CB1-knock-out mice and…
Abstract The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision. Therefore, the search of biomarkers is…
Abstract Cannabis sativa is an aromatic annual flowering plant with several botanical varieties, used for different purposes, like the production…
Abstract Dravet syndrome is a catastrophic epilepsy of childhood, characterized by cognitive impairment, severe seizures, and increased risk for sudden…
Abstract Silicon is a non-essential element for plants and is available in biota as silicic acid. Its presence has been…
Abstract Cannabis abuse during adolescence confers an increased risk for developing later in life cognitive deficits reminiscent of those observed…